Table 3 Association between miR-34a expression levels and overall survivals

Overall

18

1691

1.600 (1.44–1.77)

1.86 (1.52–2.28)

58.7%

0.001

Ethnicity

0.806

 Asian

15

1456

1.58 (1.42–1.76)

 1.82 (1.48–2.24)

55.2%

0.005

 Caucasian

3

235

1.86 (1.25–2.76)

2.20 (0.90–5.37)

78.6%

0.009

Sample Size

0.979

  ≥ 100

7

937

1.51 (1.34–1.69)

1.61 (1.35–1.92)

36.1%

0.153

 <100

11

754

1.98 (1.59–2.48)

2.00 (1.37–2.93)

63.2%

0.002

NOS Scores

0.978

  ≥ 8

11

1100

1.53 (1.36–1.71)

1.75 (1.42–2.16)

49.5%

0.031

  < 8

7

591

2.00 (1.56–2.55)

1.87 (1.20–2.93)

65.8%

0.008

Specimen

0.933

 tissue

17

1532

1.57 (1.41–1.75)

1.87 (1.50–2.33)

60.2%

0.001

 plasma

1

159

1.88 (1.34–2.63)

1.88 (1.34–2.63)

–

–

Cancer Types

0.494

 EC

2

210

1.69 (1.04–2.74)

1.87 (0.88–4.00)

45.6%

0.175

 GC

5

457

1.33 (1.13–1.57)

1.25 (0.59–2.65)

68.3%

0.013

 HCC

4

339

1.60 (1.33–1.92)

1.84 (1.30–2.59)

48.7%

0.119

 PC

4

460

2.27 (1.77–2.89)

2.59 (1.69–3.97)

57.1%

0.072

 CRC

2

148

1.59 (1.03–2.47)

1.59 (1.03–2.47)

0.0%

0.556

 GBC

1

77

2.37 (1.11–5.06)

2.37 (1.11–5.06)

–

–